Leigh Morgan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Leigh Morgan

Leigh Morgan was last confirmed as Board Member at Kymera Therapeutics, Inc. (KYMR) in a filing dated April 29, 2025. Kymera Therapeutics, Inc. reported in an 8-K filed July 8, 2022 that Leigh Morgan was appointed Class II director, effective July 6, 2022.

“On July 1, 2022, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Kymera Therapeutics, Inc. (the "Company"), the Board appointed Leigh Morgan to join the Board, effective as of July 6, 2022.”

Kymera Therapeutics, Inc. Form 8-K, filed July 8, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Leigh Morgan's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Kymera Therapeutics, Inc. (KYMR)
Board Member

Proxy statement

2022-01-01–2025-04-29

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Kymera Therapeutics, Inc.

KYMR

Board Member

Since 2022-01-01, last confirmed 2025-04-29

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Class II director Kymera Therapeutics, Inc. (KYMR)
2022-07-06